Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending June 30, 2023 was 2.68 (a -41.84% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -48.55%
- Annual Net Debt/EBITDA for 2022 was 1.34 (a -42.88% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was 2.35 (a -60.62% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was 5.97 (a 452.76% increase from previous year)
Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Dyne Therapeutics, Inc.Most recent Net Debt/EBITDAof DYN including historical data for past 10 years.
Interactive Chart of Net Debt/EBITDA of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
Business Profile of Dyne Therapeutics, Inc.